Blood pressure treatment: how low should you go? – Authors' reply by Rahimi, K, Bidel, Z, Nazarzadeh, M, Copland, E, Canoy, D

Uptake of COVID-19 vaccination in people with blood cancer: population-level cohort study of 12 million patients in England by Hirst, J, Mi, E, Copland, E, Patone, M, Coupland, C, Hippisley-Cox, J

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease? by Canoy, D, Nazarzadeh, M, Copland, E, Bidel, Z, Rao, S, Li, Y, Rahimi, K

Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort... by Chen, DT, Copland, E, Hirst, JA, Mi, E, Dixon, S, Coupland, C, Hippisley-Cox, J

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-le... by Rahimi, K, Nazarzadehlarzjan, M, Bidel, Z, Copland, E, Canoy, D, Wamil, M, Majert, J, McManus, RJ

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis by Nazarzadeh Larzjan, M, Bidel Taleshmekaeil, Z, Canoy, D, Copland, E, Wamil, M, Majert, J, Bennett, D, Rahimi, K

The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports by Nazarzadeh, M, Canoy, D, Bidel, Z, Copland, E, Rahimi, K, Teo, K, Davis, BR, Chalmers, J, Pepine, CJ, Woodward, M

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials by Pinho-Gomes, A, Azevedo, L, Bidel, Z, Nazarzadeh, M, Canoy, D, Copland, E, Salam, A, Rodgers, A, Kotecha, D, Rahimi, K

Stratification of diabetes in the context of comorbidities, using representation learning and topological data analysis by Wamil, M, Hassaine, A, Rao, S, Li, Y, Mamouei, M, Canoy, D, Nazarzadeh, M, Bidel, Z, Copland, E, Rahimi, K, Salimi-Khorshidi, G

Long-term exposure to elevated systolic blood pressure in predicting incident cardiovascular disease: evidence from large-scale routine electronic health records by Solares, JR, Canoy, D, Raimondi, FED, Zhu, Y, Hassaine, A, Salimi-Khorshidi, G, Tran, J, Copland, E, Zottoli, M, Gomes, A-C, Nazarzadeh, M, Rahimi, K

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials by Canoy, D, Copland, E, Nazarzadeh, M, Ramakrishnan, R, Pinho-Gomes, A-C, Salam, A, Dwyer, JP, Farzadfar, F, Sundström, J, Woodward, M, Davis, BR, Rahimi, K

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis by Pinho-Gomes, A-C, Azevedo, L, Copland, E, Canoy, D, Nazarzadeh, M, Ramakrishnan, R, Berge, E, Sundström, J, Kotecha, D, Woodward, M, Teo, K, Davis, BR, Chalmers, J, Pepine, CJ, Rahimi, K

Sex-specific effects of blood pressure lowering pharmacotherapy for the prevention of cardiovascular disease: an individual participant-level data meta-analysis by Bidel, Z, Nazarzadeh, M, Canoy, D, Copland, E, Gerdts, E, Woodward, M, Gupta, AK, Reid, CM, Cushman, WC, Wachtell, K, Teo, K, Davis, BR, Chalmers, J, Pepine, CJ, Rahimi, K, Blood Pressure Lowering Treatment Trialists’ Collaboration

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis by Nazarzadeh, M, Bidel, Z, Canoy, D, Copland, E, Bennett, DA, Dehghan, A, Davey Smith, G, Holman, RR, Woodward, M, Gupta, A, Adler, AI, Wamil, M, Sattar, N, Cushman, WC, McManus, RJ, Teo, K, Davis, BR, Chalmers, J, Pepine, CJ, Rahimi, K